Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GASTRICHIP: D2 Resection and HIPEC in Locally Advanced Gastric Carcinoma
NCT01882933Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2013
- Primary completion
- Jun 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of oxaliplatin in gastric adenocarcinoma, sponsored by Hospices Civils de Lyon. Started Jun 2013; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01882933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882933.